Tufts-CEVR HEOR Leaders Survey

How will HEOR leaders respond to recent policy changes? A survey from Tufts and the Center for the Evaluation of Value and Risk in Health (CEVR) provides the answer. About 2/3 of the n=57 respondents were Head of their HEOR department and the remaining 1/3 had some other senior level HEOR role. Three key topic…

Read More

Beam’s Base-Editing Sickle Cell Therapy Shows Early Promise, But a Fatality Overshadows Results

The death wasn’t due to Beam Therapeutics’ sickle cell disease therapy, BEAM-101, but was instead attributed to the preconditioning treatment needed before the genetic medicine is infused. A different Beam program in preclinical development could avoid the need for toxic preconditioning; data from both programs will be presented during the upcoming American Society of Hematology…

Read More

What to Know About CMS’ New Proposed Outpatient Payment Rule

CMS published its proposed 2027 outpatient payment rule, including a 2.4% base rate increase alongside steep cuts to 340B drug payments and an expansion of site-neutral payment to off-campus imaging services. Provider groups warn that these changes would push many hospitals’ payments into negative territory. The post What to Know About CMS’ New Proposed Outpatient…

Read More